144 related articles for article (PubMed ID: 36007607)
21. Arsenic exposure elevated ROS promotes energy metabolic reprogramming with enhanced AKT-dependent HK2 expression.
Lou Q; Zhang M; Zhang K; Liu X; Zhang Z; Zhang X; Yang Y; Gao Y
Sci Total Environ; 2022 Aug; 836():155691. PubMed ID: 35525345
[TBL] [Abstract][Full Text] [Related]
22. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
23. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
24. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
25. FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis.
Wang P; Cong M; Liu T; Li Y; Liu L; Sun S; Sun L; Zhu Z; Ma H; You H; Zhang H; Jia J
J Cell Physiol; 2020 Dec; 235(12):9524-9537. PubMed ID: 32495363
[TBL] [Abstract][Full Text] [Related]
26. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII.
Guo Y; Wei L; Zhou Y; Lu N; Tang X; Li Z; Wang X
Free Radic Biol Med; 2020 Jan; 146():119-129. PubMed ID: 31669347
[TBL] [Abstract][Full Text] [Related]
27. Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells.
Liu Y; Cheng H; Zhou Y; Zhu Y; Bian R; Chen Y; Li C; Ma Q; Zheng Q; Zhang Y; Jin H; Wang X; Chen Q; Zhu D
Cell Death Dis; 2013 Feb; 4(2):e494. PubMed ID: 23412387
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β.
Cuadrado-Tejedor M; Vilariño M; Cabodevilla F; Del Río J; Frechilla D; Pérez-Mediavilla A
J Alzheimers Dis; 2011; 23(2):195-206. PubMed ID: 20930307
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
30. Glucose-6-phosphate tips the balance in modulating apoptosis in cerebellar granule cells.
Bobba A; Amadoro G; La Piana G; Petragallo VA; Calissano P; Atlante A
FEBS Lett; 2015 Feb; 589(5):651-8. PubMed ID: 25647035
[TBL] [Abstract][Full Text] [Related]
31. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C
J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101
[TBL] [Abstract][Full Text] [Related]
32. Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis.
Zhou H; Zhang Y; Hu S; Shi C; Zhu P; Ma Q; Jin Q; Cao F; Tian F; Chen Y
J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28398674
[TBL] [Abstract][Full Text] [Related]
33. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.
Wolf A; Agnihotri S; Micallef J; Mukherjee J; Sabha N; Cairns R; Hawkins C; Guha A
J Exp Med; 2011 Feb; 208(2):313-26. PubMed ID: 21242296
[TBL] [Abstract][Full Text] [Related]
34. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
35. Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): Implication for the design of new cancer therapies.
Rosano C
Mitochondrion; 2011 May; 11(3):513-9. PubMed ID: 21315184
[TBL] [Abstract][Full Text] [Related]
36. Relationship between expression of voltage-dependent anion channel (VDAC) isoforms and type of hexokinase binding sites on brain mitochondria.
Poleti MD; Tesch AC; Crepaldi CR; Souza GH; Eberlin MN; de Cerqueira César M
J Mol Neurosci; 2010 May; 41(1):48-54. PubMed ID: 19688190
[TBL] [Abstract][Full Text] [Related]
37. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract][Full Text] [Related]
38. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
39. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
40. The effect and mechanism of hexokinase-2 on cisplatin resistance in lung cancer cells A549.
Xie S; Li X; Zhao J; Zhang F; Shu Z; Cheng H; Liu S; Shi S
Environ Toxicol; 2024 May; 39(5):2667-2680. PubMed ID: 38224486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
